Menacal-D chewable tablet is indicated for the treatment and prevention of:

• Deficiency of Menaquinone-7, Calcium & Vitamin D3

• Osteoporosis

• Rheumatoid arthritis

• Rickets

• Development of bone and teeth in children

K2Cal tablet is indicated for treatment and prevention of:

• Deficiency of Menaquinone-7, Calcium & Vitamin D3
• Osteoporosis
• Arthritis
• Osteomalacia
• Osteogenesis
• Pancreatitis
• Tetany
• Hypoparathyroidism
• Hyperphosphatemia

MenaCal-D chewable tablet contains:

• Menaquinone-7 (Vitamin K2): 75 mcg
• Calcium (Red Algae): 264 mg
• Vitamin D3 (Cholecalciferol): 200 IU

K2Cal tablet contains:

• Menaquinone-7 (Vitamin K2): 45 mcg
• Calcium (Red Algae): 500 mg
• Vitamin D3 (Cholecalciferol): 1000 IU

Menaquinone-7 is the active trans-isomer of natural Vitamin K2 with the highest bioavailability and longest half-life in the blood. It is a powerful cofactor in transporting excess calcium out of the arteries and depositing it into the bones. Red Algae Calcium (Algas Calcareas) is a plant-based natural calcium derived from marine algae. The algae predigests the calcium and minerals found in it, thus the calcium is easily broken down to be absorbed in the human body. Vitamin D3 helps in the absorption of calcium from the gastrointestinal tract and helps to maintain calcium balance in the body. The combination of Red Algae Calcium with Menaquinone-7, Vitamin D3, and trace minerals can play a vital role in formation and maintaining healthy bone and teeth in children, disorders of osteogenesis, latent tetany, hypoparathyroidism, and pancreatitis.

Menacal-D chewable tablet:

• Children: Orally 1 chewable tablet daily or as advised by the physician.
• Adolescent: Orally 1-2 chewable tablets daily or as advised by the physician.
• Adult: Orally 2 chewable tablets daily or as advised by the physician.
• The tablet should be chewed and should not be swallowed directly.

K2Cal tablet:

• Orally 1 tablet 1-2 times daily after a meal or as advised by the physician.

Menaquinone-7 may alter the effect of Warfarin. Concomitant use with Orlistat may decrease the absorption of Menaquinone-7. Oral Calcium can reduce the absorption of Tetracycline and Fluoride preparations; thus, a minimum of 3 hours should be allowed between ingestion of these medications. Thiazide diuretics reduce the renal excretion of Calcium. Concomitant ingestion of certain foods like spinach, cereals, milk, and its derivatives may reduce the intestinal uptake of Calcium. Phenytoin, Barbiturates, and Glucocorticoids may induce the metabolism of Vitamin D3.

 Contraindicated in patients with known hypersensitivity to Menaquinone-7, Calcium, or Vitamin D3; hypocalcemia resulting from an overdose of Vitamin D3; hyperparathyroidism; bone metastases; severe renal insufficiency; severe hypercalciuria; renal calculi, etc.

Generally well tolerated at the recommended dose. Constipation or stomach upset may occur occasionally.

Can be given to pregnant and lactating mothers as advised by the physician.

Consult your doctor before taking Marincal-D Tablet if you are breastfeeding. Marincal-D Tablet is usually safe and does not interact with your driving ability. It is advised to seek a doctor's advice before starting Marincal-D Tablet if you have kidney diseases like kidney stones or are undergoing dialysis. Caution should be taken in patients undergoing dialysis before starting Marincal-D Tablet. Let your doctor know if you have any history of liver diseases before taking Marincal-D Tablets. Drinking alcohol can affect calcium absorption; hence, it is advised to limit alcohol intake while using Marincal-D Tablet.

Herbal and Nutraceuticals, Specific mineral & vitamin combined preparations

Do not store above 30°C. Protect from light and moisture. Keep out of reach of children.